Dare Bioscience, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Dar Bioscience, Inc. has filed an S-1 registration statement to allow for the resale of up to 8,934,345 shares of common stock by selling stockholders, primarily issuable upon exercise of outstanding warrants.
NASDAQ
Dar Bioscience has filed a registration statement for the resale of up to 2.75 million shares of its common stock by Lincoln Park Capital Fund, LLC.